With India's in vitro diagnostic market expected to grow at a 13% rate over the next several years, Roche Diagnostics ($RHHBY) views business prospects there as an enormous growth opportunity, Lance Little, managing director for the company's Indian operations, told The Times of India. To boost business, Roche plans to provide training and engineering support to labs that choose to use the company's diagnostics products. Among the products Roche will focus on, according to the story: Screening tests to ensure safe blood transfusions and a high-risk HPV diagnostic test. Story